These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 25743081)

  • 1. Targeting the translation machinery in cancer.
    Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
    Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.
    Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S
    Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets.
    Sehrawat U
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological and therapeutic relevance of mRNA translation in cancer.
    Blagden SP; Willis AE
    Nat Rev Clin Oncol; 2011 May; 8(5):280-91. PubMed ID: 21364523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Translation of mRNA as a Therapeutic Strategy in Cancer.
    Pal I; Safari M; Jovanovic M; Bates SE; Deng C
    Curr Hematol Malig Rep; 2019 Aug; 14(4):219-227. PubMed ID: 31231778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasticity of mRNA translation during cancer progression and therapy resistance.
    Fabbri L; Chakraborty A; Robert C; Vagner S
    Nat Rev Cancer; 2021 Sep; 21(9):558-577. PubMed ID: 34341537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation initiation factors and cancer.
    Ali MU; Ur Rahman MS; Jia Z; Jiang C
    Tumour Biol; 2017 Jun; 39(6):1010428317709805. PubMed ID: 28653885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development.
    Pelletier J; Graff J; Ruggero D; Sonenberg N
    Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment.
    Bartish M; Abraham MJ; Gonçalves C; Larsson O; Rolny C; Del Rincón SV
    Nat Rev Cancer; 2023 Jun; 23(6):408-425. PubMed ID: 37142795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting translation regulators improves cancer therapy.
    Jiang SL; Mo JL; Peng J; Lei L; Yin JY; Zhou HH; Liu ZQ; Hong WX
    Genomics; 2021 Jan; 113(1 Pt 2):1247-1256. PubMed ID: 33189778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Plasticity: The Role of mRNA Translation.
    Lee LJ; Papadopoli D; Jewer M; Del Rincon S; Topisirovic I; Lawrence MG; Postovit LM
    Trends Cancer; 2021 Feb; 7(2):134-145. PubMed ID: 33067172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RNA Methyltransferase METTL3 Promotes Oncogene Translation.
    Cancer Discov; 2016 Jun; 6(6):572. PubMed ID: 27150535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
    Bitterman PB; Polunovsky VA
    Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On translational regulation and EMT.
    Evdokimova V; Tognon CE; Sorensen PH
    Semin Cancer Biol; 2012 Oct; 22(5-6):437-45. PubMed ID: 22554796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Opportunities in Eukaryotic Translation.
    Chu J; Pelletier J
    Cold Spring Harb Perspect Biol; 2018 Jun; 10(6):. PubMed ID: 29440069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies.
    Hagner PR; Schneider A; Gartenhaus RB
    Blood; 2010 Mar; 115(11):2127-35. PubMed ID: 20075156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation.
    Bitterman PB; Polunovsky VA
    Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of translation initiation as cancer therapeutics.
    Lindqvist L; Pelletier J
    Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
    Pettersson F; Del Rincon SV; Miller WH
    Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the eIF4A RNA helicase as an anti-neoplastic approach.
    Chu J; Pelletier J
    Biochim Biophys Acta; 2015 Jul; 1849(7):781-91. PubMed ID: 25234619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.